|
Post by sportsrancho on Oct 8, 2017 9:45:12 GMT -5
$20 is what AMGN will offer in the buy out, right? I'd vote against this hypothetical offer, wouldn't you? Al would have.
|
|
|
Post by careful2invest on Oct 8, 2017 9:59:35 GMT -5
Let's remember that $20 now is only $4 pre split. $4 for an FDA approved, SUPERIOR, actual human insulin for mealtime Diabetes treatment? That traded over $10 pre split just after approval? Which woud be over $50 now?
$20 is not out of the question right now! The pps was coruptly taken from it's post approval high mostly by market manipulation/shorts etc... I am hoping for an honest correction sooner than later! Once the launch boasting that Afrezza is Superior is well known to all, $20 will be just a blip in where the pps of this stock will end up! This will be huge! GO MNKD! THE SKY IS THE LIMIT!
|
|
|
Post by slugworth008 on Oct 8, 2017 10:00:18 GMT -5
$20 is what AMGN will offer in the buy out, right? I'd vote against this hypothetical offer, wouldn't you? Absolutely! Al sold his companies for 8-10x his investment. Why should MNKD be any different?
|
|
|
Post by MnkdWASmyRtrmntPlan on Oct 8, 2017 11:11:18 GMT -5
well I am already retired 15 years with a government pension, I got a paid off house 1.5 miles from the beach, do exactly what I want do every day... Congratulations, Kuka. It sounds like you won the game a long time ago.
|
|
|
Post by MnkdWASmyRtrmntPlan on Oct 8, 2017 11:13:03 GMT -5
I'd vote against this hypothetical offer, wouldn't you? Absolutely! Al sold his companies for 8-10x his investment. Why should MNKD be any different? Exactly, Slugworth. Not $20 ... maybe $200!!! A buyout is always possible, but I don't think it will happen. I think Mike's is doing everything he can to keep that from happening. He's playing to win ... like Kuka.
|
|
|
Post by afrezza on Oct 8, 2017 12:50:09 GMT -5
How is that possible ? You had more than enough possibilities / time to average down... unless You spent Your entire savings before...
|
|
|
Post by cjm18 on Oct 8, 2017 13:03:12 GMT -5
I'd vote against this hypothetical offer, wouldn't you? Absolutely! Al sold his companies for 8-10x his investment. Why should MNKD be any different? La times article said he spent 975million. 8-10 billion market cap= 80-100 pps.
|
|
|
Post by steve on Oct 8, 2017 19:07:57 GMT -5
Sometimes overnight.
|
|
|
Post by doingmybest on Oct 9, 2017 6:20:57 GMT -5
Patient awareness...patient awareness...patient awareness....should be the main focus going forward. Most physicians are overburdened with work and many are so busy they are not taking on new patients. Its human nature...they will not pursue this change in their patients medical treatment unless their patient ASKS for it. They're not selfish professionals...they simply don't need to make their job more involved setting up their patients with a new diabetes treatment. However they do care for their patients and will do whatever they are asked to enhance their lives in any way. I would suggest a major advertising campaign possibly depicting a patient excusing themselves at a restaurant, taking out their medical insulin package, and then the painful invasive treatment of an insulin injection. The next scene might show the same patient having a pleasant conversation before dinner...then without missing a beat...a quick inhale of Afrezza, and then enjoying dinner with their friend. I know what I would want. This is an outstanding improvement to an age long treatment method, that years from now, we will be looking back in bewilderment on the treatment that had patients injecting themselves three times a day to manage their blood sugar during meal times. When the so called "analysts" were putting a doomsday scenario on this amazing product, I held steadfast in knowing that this is going to be something GREAT!
|
|
|
Post by anderson on Oct 9, 2017 7:18:19 GMT -5
Absolutely! Al sold his companies for 8-10x his investment. Why should MNKD be any different? Exactly, Slugworth. Not $20 ... maybe $200!!! A buyout is always possible, but I don't think it will happen. I think Mike's is doing everything he can to keep that from happening. He's playing to win ... like Kuka. Al mentioned that MNKD was the most valuable company he ever created. Think there was a mention pre FDA approval that he though it was worth at least $300 a share(note that would be $1500 post split), though he never gave a time frame for it to reach that level.
|
|
|
Post by cjm18 on Oct 9, 2017 7:26:39 GMT -5
Exactly, Slugworth. Not $20 ... maybe $200!!! A buyout is always possible, but I don't think it will happen. I think Mike's is doing everything he can to keep that from happening. He's playing to win ... like Kuka. Al mentioned that MNKD was the most valuable company he ever created. Think there was a mention pre FDA approval that he though it was worth at least $300 a share(note that would be $1500 post split), though he never gave a time frame for it to reach that level. 150billion market cap? Need at least 20b revenue to be in that conversation. en.m.wikipedia.org/wiki/List_of_largest_pharmaceutical_companies_by_revenue
|
|
|
Post by MnkdWASmyRtrmntPlan on Oct 11, 2017 7:18:58 GMT -5
How is that possible ? You had more than enough possibilities / time to average down... unless You spent Your entire savings before... Was that question directed at me? I was referring to the hypothetical $20 buyout offer from Amgen that was discussed above ... not the amount needed to retire.
|
|
|
Post by dreamboatcruise on Oct 11, 2017 11:03:53 GMT -5
Exactly, Slugworth. Not $20 ... maybe $200!!! A buyout is always possible, but I don't think it will happen. I think Mike's is doing everything he can to keep that from happening. He's playing to win ... like Kuka. Al mentioned that MNKD was the most valuable company he ever created. Think there was a mention pre FDA approval that he though it was worth at least $300 a share(note that would be $1500 post split), though he never gave a time frame for it to reach that level. Pointless to talk about a share price mentioned by Al without considering the significant increase in share count that has occurred since then and assets divested for operating expenses.
|
|